Delivery Order SPE2DB20D3103-SPE2DB25FP8Z7
- Not listed
- The Defense Logistics Agency awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits, with a completion date of September 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a leading pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a $8,146.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 22, 2025. This non-set-aside award represents a competitive procurement executed on August 21, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $20,091.40 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price contract, awarded on August 1, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Sandostatin LAR Depot 20 mg kits valued at $62,713.64 with firm fixed pricing. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,958.92 for Sandostatin LAR Depot 20 mg kits on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a firm fixed price contract with no set-aside designation, representing a competitively awarded delivery order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $52,498.21 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with a completion date of August 25, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the agency. The order will be fulfilled from the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $19,093.44 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in endocrinology treatment. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents performance from AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $63,498.76 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, which was not set-aside, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sandostatin LAR Depot 20 mg kits under a firm fixed-price contract valued at $21,278.56. This is a competitive award with no set-aside designation, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The delivery order is a child contract under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8Z7Delivery Order
The Defense Logistics Agency awarded a $159,383.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. Sandostatin LAR Depot is a long-acting octreotide formulation used for managing acromegaly, neuroendocrine tumors, and other conditions requiring somatostatin receptor agonist therapy. AmerisourceBergen's role as a major pharmaceutical distributor positions it as a critical vendor for the Defense Health Agency and military healthcare systems requiring specialized pharmaceutical products. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex medical supply requirements across multiple therapeutic domains through competitive procurement processes, supporting the Department of Defense's medical supply chain operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $159.4k | 8/15/25 |